about
Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results.MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett's esophagus.Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy.Oesophagectomy is a safe option for early adenocarcinoma arising from Barrett's oesophagus.MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.The use of a balloon catheter to improve evaluation in anorectal manometry.Follow-Up Practices of Surgeons and Medical Oncologists in Australia and New Zealand Following Resection of Esophagogastric Cancers.Influence of tumor response and treatment schedule on the distribution of tumor recurrence in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia.Natural history of endoscopically detected hiatus herniae at late follow-up.Randomized Trial of Division Versus Nondivision of Short Gastric Vessels During Nissen Fundoplication: 20-Year Outcomes.Toward More Efficient Surveillance of Barrett's Esophagus: Identification and Exclusion of Patients at Low Risk of Cancer.Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus.Outcome of endoscopy surveillance for Barrett's oesophagus.Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication.Improving care for patients with oesophageal and gastric cancer: impact of a statewide multidisciplinary teamArgon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus: late outcomes from two randomized trialsSurgical management of peptic ulcer bleeding by Australian and New Zealand upper gastrointestinal surgeonsOutcome for Asymptomatic Recurrence Following Laparoscopic Repair of Very Large Hiatus HerniaCirculating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal AdenocarcinomaEndoscopic repair of esophagogastric fistulaRetrospective analysis of surgery and trans-arterial embolization for major non-variceal upper gastrointestinal bleedingBeware of NSAID abuse: think twice before operating!Effectiveness of Nissen fundoplication versus anterior and posterior partial fundoplications for treatment of gastro-esophageal reflux disease: a systematic review protocolPattern of care for cancer of the oesophagus in a western populationIdentification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation SequencingThe role of rehabilitation in patients undergoing oesophagectomy for cancer and pre-malignant disease: A qualitative exploration of the views of patients, carers and healthcare providersPreferences for Surveillance of Barrett's Oesophagus: a Discrete Choice Experiment
P50
Q33307485-0CF0FB3E-1969-45B6-B47E-FB2F4664126EQ33405279-7827CE64-4CA9-4A97-877B-910B7BA4DF75Q38035457-E44419A3-63A0-40AC-AAF2-9A9A17B2611CQ39017855-3E6D8D8F-233E-4BE8-B258-68349CD25C64Q40516487-0D8D213A-EA1D-41E7-A4EB-B89D2EF647F2Q41426289-D6C943F5-2EF2-4C50-BC76-F6996F70E17DQ43317659-C608AD46-438A-4C07-AED8-F322CCA633C5Q47146432-DC0C6D50-FF94-43CE-9E30-148FF5C780D1Q48157174-91C142A4-CD42-4161-ACD1-CD5BCED5EB80Q48435798-9D6FCD1B-1A1B-4782-B645-F1CDC1D92D13Q49373591-C5B4CB42-D285-4306-94F9-91F40C9C1B99Q50173560-A6B9E001-25C1-41B7-8728-B478F2C44098Q51325667-4CD448E9-FAF8-4E17-B31D-B64358DD07FBQ51779945-04BFEADA-8D00-49FB-B814-64724BC0617CQ53482774-5ECD9727-51C2-4598-9266-E4A576D70387Q53521006-C23CB427-A4E9-43D5-B761-B3DD9B82E3E5Q85694768-A84F3A04-4238-41BA-BFB1-BD782E963317Q85708518-F268A4E0-270C-44D0-A642-BE8D407B4046Q86594804-08FFBB3D-F108-4D31-A922-5E708EE663D3Q87018084-A0BF89F5-62B0-4CD6-82A2-4B1DF15C60C4Q87248595-27FD54D3-3B29-48A5-96C4-22883DF1FDBCQ87454682-D045E6B3-1C46-4F4D-9B6C-04838799DAEAQ87606073-474D4828-6BD5-49B6-89DF-580FBBF66FB0Q88011966-D658F409-9453-4DDD-906E-15A52941ED38Q88676802-544D8544-C088-457B-8A0A-A1521CD3235BQ89048575-3E613C7E-9929-4E71-8E09-B805C1D2AF25Q89483551-7055F516-A5C9-45DA-8904-739C71801EE2Q91190928-1342E11A-E773-4FA7-AB60-E98528C7D4A3Q93382539-CC84504B-881F-429A-A182-EB88FBC98CBF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tim Bright
@ast
Tim Bright
@en
Tim Bright
@es
Tim Bright
@nl
Tim Bright
@sl
type
label
Tim Bright
@ast
Tim Bright
@en
Tim Bright
@es
Tim Bright
@nl
Tim Bright
@sl
prefLabel
Tim Bright
@ast
Tim Bright
@en
Tim Bright
@es
Tim Bright
@nl
Tim Bright
@sl
P106
P21
P31
P496
0000-0003-3700-5262